|

Exercise as Maintenance Therapy in Advanced Lung Cancer

RECRUITINGN/ASponsored by Indiana University
Actively Recruiting
PhaseN/A
SponsorIndiana University
Started2024-10-15
Est. completion2029-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites

Summary

The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age ≥ 18 years
2. Known diagnosis of locally advanced (stage III) or metastatic NSCLC
3. Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy

   1. Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy
   2. Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible.
4. Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program

   a.Participants must have internet access and equipment to participate in virtual exercise
5. ECOG performance status of 0-2

Exclusion Criteria:

1. Already meeting exercise guidelines and participating in at least 150 minutes of moderate or vigorous exercise per IPAQ
2. Unable to participate in the supervised home-based exercise program as determined by the MOVE program
3. Medical co-morbidities that preclude patient from participating in supervised exercise, including but not limited to:

   * Advanced heart failure
   * Advanced respiratory disease requiring home oxygen use
   * Uncontrolled psychiatric disorders
   * History of fragility fracture

Conditions4

CancerLung CancerMetastatic Lung CancerNon Small Cell Lung Cancer

Locations3 sites

Indiana University Health Methodist Hospital
Indianapolis, Indiana, 46202
Malori Pojar(317) 274-0930mpojar@iu.edu
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202
Malori Pojar(317) 274-0930mpojar@iu.edu
Sidney and Lois Eskenazi Hospital
Indianapolis, Indiana, 46202
Malori Pojar(317) 274-0930mpojar@iu.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.